Probiotics for the prevention of clostridium difficile

Canadian Family Physician

Volumn 59, Issue 9, 2013, Pages 957-

  Rainkie, Daniel ^a   Kolber, Michael R ^b  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ANTIBIOTIC ASSOCIATED DIARRHEA; CLOSTRIDIUM DIFFICILE INFECTION; DRUG COST; DRUG SAFETY; HUMAN; INCIDENCE; INFECTION CONTROL; META ANALYSIS (TOPIC); NONHUMAN; NOTE; PRACTICE GUIDELINE; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; HUMANS; PROBIOTICS;

EID: 84884360539     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. Johnston BC, Ma SSY, Goldenberg JZ, Thorlund K, Vandvik PO, Loeb M, et al. Probiotics for the prevention of Clostridium difficile-Associated diarrhea: A systematic review and metaanalysis. Ann Intern Med 2012;157(12):878-88.
2. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JNV, Shanman R, et al. Probiotics for the prevention and treatment of antibiotic-Associated diarrhea: A systematic review and metaanalysis. JAMA 2012;307(18):1959-69.
3. Goldenberg JZ, Ma SSY, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, et al. Probiotics for the prevention of Clostridium difficile-Associated diarrhea in adults and children. Cochrane Database Syst Rev 2013;(5):CD006095.
4. Dial S, Kezouh A, Dascal A, Barkun A, Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ 2008;179(8):767-72.
5. Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: Metaanalysis. Am J Gastroenterol 2012;107(7):1011-9. Epub 2012 Apr 24.
6. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment and prevention of Clostridium difficile infections. Am J Gastroenterol 2013;108(4):478-98. Epub 2013 Feb 26.
7. Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH. Probiotics for the prevention of pediatric antibiotic-Associated diarrhea. Cochrane Database Syst Rev 2011;(11):CD004827.
8. Hempel S, Newberry S, Ruelaz A, Wang Z, Miles JN, Suttorp MJ, et al. Safety of probiotics to reduce risk and prevent or treat disease. Evid Rep Technol Assess (Full Rep) 2011;(200):1-645.
9. Canadian Paediatric Society . Using probiotics in the paediatric population. Ottawa, ON: Canadian Paediatric Society; 2012. Available from: Www.cps.ca/docu ments/position/probiotics-In-The-Paediatric-Population. Accessed 2013 Aug 1.
10. Allen SJ, Wareham K, Wang D, Bradley C, Hutchings H, Harris W, et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-Associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): A randomised, double-Blind, placebo-Controlled, multicentre trial. Lancet 2013 Aug